These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 239806)

  • 1. Normal cardiac output during beta blockade with timolol in hypertensive patients.
    Franciosa JA; Freis ED
    Clin Pharmacol Ther; 1975 Aug; 18(2):158-64. PubMed ID: 239806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents.
    Colfer HT; Cottier C; Sanchez R; Julius S
    Hypertension; 1984; 6(2 Pt 1):145-51. PubMed ID: 6144632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of SHR hypertension and cardiac hypertrophy during prolonged beta blockade.
    Pfeffer MA; Pfeffer JM; Weiss AK; Frohlich ED
    Am J Physiol; 1977 Jun; 232(6):H639-644. PubMed ID: 18018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
    Franciosa JA; Freis ED; Conway J
    Circulation; 1973 Jul; 48(1):118-24. PubMed ID: 4150000
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA; Johnson SM; Tobian LJ
    Clin Pharmacol Ther; 1979 Dec; 26(6):676-81. PubMed ID: 387330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade.
    Dahlöf B; Andrén L; Svensson A; Hansson L
    J Hypertens Suppl; 1983 Dec; 1(2):112-5. PubMed ID: 6152739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
    Simon G; Franciosa JA; Gimenez HJ; Cohn JN
    Hypertension; 1981; 3(2):262-8. PubMed ID: 6111532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic effects of brefanolol and propranolol assessed by noninvasive methods in patients with arterial hypertension.
    Halabi A; Endell W; Halabi I; Kirch W
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):81-6. PubMed ID: 1696669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of timolol and propranolol in essential hypertension.
    Lohmöller G; Frohlich ED
    Am Heart J; 1975 Apr; 89(4):437-42. PubMed ID: 234668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic blocking therapy in hypertension: selection of patients.
    Frohlich ED; Tarazi RC; Dustan HP
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of timolol versus propranolol on hypertension and hemodynamics.
    Aronow WS; Ferlinz J; Del Vicario M; Moorthy K; King J; Cassidy J
    Circulation; 1976 Jul; 54(1):47-51. PubMed ID: 6161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of adrenergic beta-receptor blocking agents.
    Sannerstedt R
    Adv Clin Pharmacol; 1976; 11():70-8. PubMed ID: 25571
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic long-term effects of timolol at rest and during exercise in essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1976; 199(4):263-7. PubMed ID: 4957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R; Sivertsson R; Andrén L; Hansson L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S97-100. PubMed ID: 2454378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic long-term effects of beta-receptor-blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol.
    Lund-Johansen P; Ohm OJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():481S-483S. PubMed ID: 15759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of intravenous timolol in coronary artery disease.
    Chew CY; Collett J; Shah PK; Singh BN
    Clin Pharmacol Ther; 1979 Sep; 26(3):330-8. PubMed ID: 466927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.